EPFL spin-off ONWARD aims to improve the quality of life of people bound to a wheelchair by spinal cord injury. After the successful IPO in October, CEO Dave Marver looks forward to 2022, when the company is facing important milestones.

Dave Marver
CEO, ONWARD

Dave Marver joined ONWARD as CEO in 2020 and took the company public in October 2021 on the Amsterdam and Brussels stock exchanges. ONWARD develops therapies to restore movement, independence, and health in people with spinal cord injury. Verve Ventures invested in ONWARD in spring 2021. Dave has more than 25 years of experience in Medtech, having worked for Medtronic and Cardiac Science, a NASDAQ-listed company where he served as CEO. He was a medtech advisor for the World Bank, a board member of several companies, and a guest lecturer for several universities.

Invest in Startups

As one of Europe’s most active venture capital investors, we grant qualified private investors access to top-tier European startups. With investments starting at EUR/CHF 10’000, you can build your own tailored portfolio over time and diversify across stages and sectors.